51
|
Uemura KI, Hayashi T, Hiroshige T, Ueda K, Ohta K, Kanazawa T, Hirashima S, Nakiri M, Igawa T, Nakamura KI. Ectopic subcutaneous transplantation of fetal rat urogenital sinus and seminal vesicle promotes the organ growth and formation. Acta Histochem 2020; 122:151569. [PMID: 32622420 DOI: 10.1016/j.acthis.2020.151569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2019] [Revised: 05/19/2020] [Accepted: 05/20/2020] [Indexed: 11/18/2022]
Abstract
PURPOSE The fate of subcutaneously transplanted urogenital sinus (UGS) and seminal vesicle (SV) was investigated in the present study. MATERIALS AND METHODS Fetal UGS and SV extracted from 20-embryonic-day-old male normal and GFP transgenic rats were subcutaneously transplanted into 7-week-old male immunologically inhibited rats. The transplants were then examined at 2, 4, 8, and 16 weeks after transplantation. We analyzed the survival ratio, weight, and histopathology as well as the immunohistochemical characteristics of the transplanted tissues. For control experiments, 2-, 4-, 8-, and 16-week-old normal male rats were used. RESULTS Almost all of the transplanted tissues survived under the skin, and the tissue weights increased over time after transplantation. The histopathological characteristics and immunohistochemical staining pattern with certain antibodies of the transplanted tissues were similar to those of normal adult rat prostate and seminal vesicle. The transplanted GFP transgenic tissues demonstrated spontaneous growth and organ formation under the skin, showing distribution and movement of transplanted cells and tissues. CONCLUSION Subcutaneously transplanted fetal UGS and SV were able to develop into mature adult organs.
Collapse
Affiliation(s)
- Kei-Ichiro Uemura
- Division of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, Fukuoka, Japan; Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
| | - Tokumasa Hayashi
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Tasuku Hiroshige
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Keisuke Ohta
- Division of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Tomonoshin Kanazawa
- Division of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Shingo Hirashima
- Division of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| | - Kei-Ichiro Nakamura
- Division of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| |
Collapse
|
52
|
Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Tamura K, Komiyama M, Goto T, Yokomizo A, Kohei N, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Iwamoto H, Mitsuzuka K, Morooka D, Shimazui T, Yamamoto Y, Ikeshiro S, Nakagomi H, Morita K, Tomida R, Mochizuki T, Inoue T, Kitamura H, Yamada S, Ito YM, Murai S, Nishiyama H, Shinohara N. Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma. Cancer Sci 2020; 111:2460-2471. [PMID: 32402135 PMCID: PMC7385391 DOI: 10.1111/cas.14449] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2020] [Revised: 04/24/2020] [Accepted: 05/02/2020] [Indexed: 12/14/2022] Open
Abstract
The present study aimed to evaluate the efficacy of the real-world use of axitinib and to develop a prognostic model for stratifying patients who could derive long-term benefit from axitinib. This was a retrospective, descriptive study evaluating the efficacy of axitinib in patients with metastatic renal cell carcinoma that had been treated with 1 or 2 systemic antiangiogenic therapy regimens at 1 of 36 hospitals belonging to the Japan Urologic Oncology Group between January 2012 and February 2019. The primary outcome was overall survival (OS). Using a split-sample method, candidate variables that exhibited significant relationships with OS were chosen to create a model. The new model was validated using the rest of the cohort. In total, 485 patients were enrolled. The median OS was 34 months in the entire study population, whereas it was not reached, 27 months, and 14 months in the favorable, intermediate, and poor risk groups, respectively, according to the new risk classification model. The following 4 variables were included in the final risk model: the disease stage at diagnosis, number of metastatic sites at the start of axitinib therapy, serum albumin level, and neutrophil : lymphocyte ratio. The adjusted area under the curve values of the new model at 12, 36, and 60 months were 0.77, 0.82, and 0.82, respectively. The efficacy of axitinib in routine practice is comparable or even superior to that reported previously. The patients in the new model's favorable risk group might derive a long-term survival benefit from axitinib treatment.
Collapse
Affiliation(s)
- Takahiro Osawa
- Department of Urology, Hokkaido University Hospital, Sapporo, Japan
| | - Takahiro Kojima
- Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan
| | - Tomohiko Hara
- Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan
| | - Mikio Sugimoto
- Department of Urology, Kagawa University, Takamatsu, Japan
| | - Masatoshi Eto
- Department of Urology, Kyushu University, Fukuoka, Japan
| | - Ario Takeuchi
- Department of Urology, Kyushu University, Fukuoka, Japan
| | - Keita Minami
- Department of Urology, Sapporo City General Hospital, Sapporo, Japan
| | - Yasutomo Nakai
- Department of Urology, Osaka International Cancer Institute, Osaka, Japan
| | - Kosuke Ueda
- Department of Urology, Kurume University Hospital, Kurume, Japan
| | - Michinobu Ozawa
- Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Motohide Uemura
- Department of Urology, Osaka University Hospital, Suita, Japan
| | | | - Kojiro Ohba
- Department of Urology, Nagasaki University Hospital, Nagasaki, Japan
| | - Toshiro Suzuki
- Department of Urology, Shinshu University Hospital, Matsumoto, Japan
| | - Satoshi Anai
- Department of Urology, Nara Medical University, Kashihara, Japan
| | - Tetsuya Shindo
- Department of Urology, Sapporo Medical University, Sapporo, Japan
| | | | - Keita Tamura
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
| | | | - Takayuki Goto
- Department of Urology, Kyoto University, Kyoto, Japan
| | - Akira Yokomizo
- Department of Urology, Harasanshin Hospital, Fukuoka, Japan
| | - Naoki Kohei
- Department of Urology, Shizuoka General Hospital, Shizuoka, Japan
| | - Akira Kashiwagi
- Department of Urology, Teine Keijinkai Hospital, Sapporo, Japan
| | | | | | | | - Hideto Iwamoto
- Department of Urology, Tottori University, Yonago, Japan
| | | | - Daichi Morooka
- Department of Urology, Hakodate Goryoukaku Hospital, Hakodate, Japan
| | - Toru Shimazui
- Department of Urology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan
| | | | - Suguru Ikeshiro
- Department of Urology, Asahikawa Kosei Hospital, Asahikawa, Japan
| | - Hiroshi Nakagomi
- Department of Urology, University of Yamanashi Hospital, Chuo, Japan
| | - Ken Morita
- Department of Urology, Kushiro City General Hospital, Kushiro, Japan
| | - Ryotaro Tomida
- Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
| | - Tango Mochizuki
- Department of Urology, Asahikawa Kosei Hospital, Asahikawa, Japan
| | | | - Hiroshi Kitamura
- Department of Urology, Toyama Univerisity Hospital, Toyama, Japan
| | - Shuhei Yamada
- Department of Urology, Otaru General Hospital, Otaru, Japan
| | - Yoichi M Ito
- Department of Statistical Data Science, The Institute of Statistical Mathematics, Tokyo, Japan
| | - Sachiyo Murai
- Department of Urology, Hokkaido University Hospital, Sapporo, Japan
| | | | - Nobuo Shinohara
- Department of Urology, Hokkaido University Hospital, Sapporo, Japan
| | | |
Collapse
|
53
|
Abstract
Retreating subduction zones such as the Lesser Antilles, Gibraltar and Scotia have been migrating towards the Atlantic Ocean by cutting their way through the oceanic crust. This spontaneously retreating subduction is enabled by the development of faults at the edges of the slab, but the physical mechanisms controlling fault propagation and direction remain unknown. Here, using 3D numerical subduction models we show that oceanic lithosphere recycling is mainly controlled by the intensity of strain-induced weakening of fractures forming at the edges of the slab. Intense strain-induced weakening causes predominantly brittle fault propagation and slab narrowing until detachment. Without weakening, preponderantly ductile slab edge propagation occurs, which causes slab widening. This rheological control is not affected by the proximity of non-weakened passive continental margins. Natural examples suggest that slab edges follow convergent paths that could be controlled by fractures weakening due to deep water penetration into the oceanic lithosphere.
Collapse
Affiliation(s)
- Jessica Munch
- Department of Earth Sciences, Institute of Geophysics, ETH Zürich, Zürich, Switzerland.
| | - Taras Gerya
- Department of Earth Sciences, Institute of Geophysics, ETH Zürich, Zürich, Switzerland
| | - Kosuke Ueda
- Department of Earth Sciences, Institute of Geophysics, ETH Zürich, Zürich, Switzerland
| |
Collapse
|
54
|
Ueda K, Ogasawara N, Yonekura S, Matsunaga Y, Hoshino R, Kurose H, Chikui K, Uemura K, Nakiri M, Nishihara K, Matsuo M, Suekane S, Igawa T. The Prognostic Value of Systemic Inflammatory Markers in Advanced Renal Cell Carcinoma Patients Treated With Molecular Targeted Therapies. Anticancer Res 2020; 40:1739-1745. [PMID: 32132082 DOI: 10.21873/anticanres.14127] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 02/06/2020] [Accepted: 02/07/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM The present study examined the impact of systemic inflammatory markers including C-reactive protein (CRP)/Albumin (Alb) and neutrophil lymphocyte ratio (NLR)/Alb on the prognosis of patients treated with first line molecular targeted therapy for advanced RCC. PATIENTS AND METHODS A total of 131 patients with advanced RCC treated with molecular targeted therapy as first line treatment from May 2008 to April 2019 were retrospectively analyzed. RESULTS High CRP, high NLR, low Alb and high CRP/Alb showed significantly worse progression-free survival (PFS) and overall survival (OS) than low CRP, low NLR, high Alb, low CRP/Alb and low NLR/Alb, respectively. In multivariate analyses, prior nephrectomy (p=0.0321) and NLR/Alb ratio (p=0.0327) were independent prognostic factors for PFS. Furthermore, prior nephrectomy (p=0.0013) and CRP/Alb ratio (p=0.0020) were independent prognostic factors for OS. CONCLUSION CRP/Alb and NLR/Alb ratios are useful and independent prognostic biomarkers in patients with advanced RCC treated with molecular targeted therapy.
Collapse
Affiliation(s)
- Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Naoyuki Ogasawara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | | | | | - Ryuji Hoshino
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Hirofumi Kurose
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Katsuaki Chikui
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Keiichiro Uemura
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Mitsunori Matsuo
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Shigetaka Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| |
Collapse
|
55
|
Murakami R, Matsuo N, Ueda K, Nakazawa M. Epidemiological and spatial factors for tuberculosis: a matched case-control study in Nagata, Japan. Int J Tuberc Lung Dis 2020; 23:181-186. [PMID: 30808450 DOI: 10.5588/ijtld.18.0369] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
SETTING AND OBJECTIVE Several studies have found a significant association between tuberculosis (TB) and spatial factors. We wished to determine the effect of host-related factors and spatial factors associated with an increased risk of TB, and to assess spatial clustering. DESIGN A hospital-based case-control study using medical records was conducted. A total of 103 age- and sex-matched TB patients (cases) and 299 patients without TB (controls) were recruited from January 2000 to December 2016 in a hospital in Nagata, Kobe, Japan. Logistic regression, kernel density estimation, Cross L function and a Poisson regression model were applied. RESULTS The epidemiological factors associated with TB were being a health care worker (OR 10.1) and lower serum albumin level (OR 0.5). Spatial analyses revealed TB to be positively associated with population density (risk ratio [RR] 32.1), the proportion of single households (RR -1.85) and persons aged 65 years (RR 2.65) and one spatial clustering. CONCLUSION Our findings could help in the identification of high TB risk individuals and districts.
Collapse
Affiliation(s)
- R Murakami
- Department of Public Health, Graduate School of Health Sciences, Kobe University, Hyogo
| | - N Matsuo
- Department of Internal Medicine, Kobe Kyodo Hospital, Hyogo, Japan
| | - K Ueda
- Department of Internal Medicine, Kobe Kyodo Hospital, Hyogo, Japan
| | - M Nakazawa
- Department of Public Health, Graduate School of Health Sciences, Kobe University, Hyogo
| |
Collapse
|
56
|
Ueda K, Yonekura S, Ogasawara N, Matsunaga Y, Hoshino R, Kurose H, Chikui K, Uemura K, Nakiri M, Nishihara K, Matsuo M, Suekane S, Igawa T. The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors. Anticancer Res 2019; 39:6265-6271. [PMID: 31704856 DOI: 10.21873/anticanres.13836] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 10/14/2019] [Accepted: 10/15/2019] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM The present study aimed to examine the influence of antibiotics (AB) on the clinical outcomes of Japanese patients treated with immune check point inhibitors (ICIs) for metastatic renal cell carcinoma (RCC) patients. PATIENTS AND METHODS A total of 31 patients with metastatic RCC treated with ICIs from November 2016 to April 2019 were retrospectively reviewed and analyzed. RESULTS Five patients were treated with AB prior to ICIs treatment. Median progression free survival (PFS) of patients treated with AB vs. patients not treated with AB was 2.8 months and 18.4 months, respectively. The difference between PFS was statistically significant (p=0.0004). In multivariate analyses, AB use (p=0.0377) and presence of immune related adverse events (p=0.0042) were independent prognostic factors for PFS in association with ICIs therapy. CONCLUSION The use of AB before ICIs treatment was a predictor of poor ICIs response in metastatic RCC.
Collapse
Affiliation(s)
- Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan .,Gustave Roussy Cancer Campus, Villejuif, France
| | | | - Naoyuki Ogasawara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | | | - Ryuji Hoshino
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Hirofumi Kurose
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Katsuaki Chikui
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Keiichiro Uemura
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Mitsunori Matsuo
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Shigetaka Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| |
Collapse
|
57
|
Kurose H, Ueda K, Kondo R, Ogasawara S, Kusano H, Sanada S, Naito Y, Nakiri M, Nishihara K, Kakuma T, Akiba J, Igawa T, Yano H. Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer. Anticancer Res 2019; 39:6249-6257. [PMID: 31704854 DOI: 10.21873/anticanres.13834] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2019] [Revised: 09/19/2019] [Accepted: 09/26/2019] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Therapeutic targeting of receptor protein tyrosine kinases (PTKs) has proven successful in treating cancer. However, reports about PTKs in treating prostate cancer are few. Elevated expression of the erythropoietin-producing hepatocellular receptor A2 (EPHA2) receptor tyrosine kinase, a transmembrane protein, is associated with poor prognosis of certain cancer types when the enzyme is dephosphorylated. This study investigated whether EPHA2 is useful in predicting the biochemical recurrence of prostate cancer. PATIENTS AND METHODS Data from 241 patients who had undergone total prostatectomy between 2007 and 2011 were used. EPHA2 protein expression was categorized as high or low by two pathologists. The relationship was examined between EPHA2 expression level (high vs. low) and clinicopathological factors including biochemical recurrence. Correlations were examined between EPHA2, low-molecular-weight protein tyrosine phosphatase (LMW-PTP), E-cadherin, and Ki-67. RESULTS EPHA2 expression was high in 121 (50.2%) and low in 120 (49.8%) patients. A log-rank test revealed early biochemical recurrence in the high-expression group. Gleason score, Ki-67 labeling index, and biochemical recurrence were more frequent in the high-expression group. Furthermore, multivariate analyses revealed that high EPHA2 expression was an independent prognostic factor for biochemical recurrence (hazard ratio=3.62, 95% confidence interval=2.39-5.61). Correlations between EPHA2 and both LMW-PTP and Ki-67 labeling index were positive, whereas EPHA2 and E-cadherin were negatively correlated. CONCLUSION EPHA2 overexpression is predictive of aggressive prostate cancer behavior. EPHA2 may be a powerful prognostic biomarker for decision-making in postoperative follow-up after total prostatectomy, and regarding the need for palliative treatment. Additionally, it may be an important therapeutic target.
Collapse
Affiliation(s)
- Hirofumi Kurose
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan .,Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Reiichiro Kondo
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Sachiko Ogasawara
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Hironori Kusano
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Sakiko Sanada
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Yoshiki Naito
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan.,Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Tatsuyuki Kakuma
- Biostatistics Center, Kurume University School of Medicine, Kurume, Japan
| | - Jun Akiba
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Hirohisa Yano
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| |
Collapse
|
58
|
Ueda K, Imada T, Ueda A, Imada M, Ozaki K. Stromal-type Nephroblastoma with or without Anaplasia in Two Hedgehogs (Atelerix albiventris). J Comp Pathol 2019; 172:48-52. [PMID: 31690414 DOI: 10.1016/j.jcpa.2019.09.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2019] [Revised: 08/26/2019] [Accepted: 09/05/2019] [Indexed: 11/29/2022]
Abstract
We describe the clinical and histological characteristics of stromal-type nephroblastomas that developed in two hedgehogs (Atelerix albiventris). In case 1, the tumour was composed of a proliferation of anaplastic stromal cells with ductal structures resembling the epithelium of nephroblastoma. In case 2, spindle-shaped cells that were somewhat larger than nephroblasts were frequently seen surrounding the cell cluster, and there was proliferation of stromal cells with collagen fibres at the periphery. Immunohistochemically, the tumour cells labelled weakly to strongly for the nephroblast marker Wilms' tumour-1 and were positive for Ki67 with rates of 5% and 10% for cases 1 and 2, respectively. Based on the above, the diagnosis was of stromal-type nephroblastoma with anaplasia in case 1 and without anaplasia in case 2. Our findings suggest that stromal-type nephroblastomas arise in adult hedgehogs and are clinically benign, and that histological anaplasia does not affect the prognosis.
Collapse
Affiliation(s)
- K Ueda
- Vogel Animal Hospital, Kobe, Hyogo, Japan
| | - T Imada
- Kasumigaoka Animal Hospital, Sakai, Osaka, Japan
| | - A Ueda
- Vogel Animal Hospital, Kobe, Hyogo, Japan
| | - M Imada
- Kasumigaoka Animal Hospital, Sakai, Osaka, Japan
| | - K Ozaki
- Laboratory of Pathology, Setsunan University, Osaka, Japan.
| |
Collapse
|
59
|
Waki K, Ueda K, Satoh K, Ogino K, Hayashi T, Arakaki Y. P3735Incidence of bicuspid aortic valve in 16,185 neonates by echocardiographic screening in a single institution: is it really congenial? Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Bicuspid aortic valve (BAV) has been reported to be the most common congenital heart disease with an incidence of 1 to 2% in the general population; however, its incidence in neonates is still unclear because most of the reported incidence data are based on surgical or autopsy cases in adults.
Purpose
To elucidate the true incidence of congenital isolated BAV in neonates by echocardiographic screening in a population-based study.
Methods
We examined a total of 16,185 full-term neonates (male, 48.9%) born in our institution during either of the following two periods: September 1986 to February 2008 and October 2014 to September 2017. Mean gestational age (range) was 39.4 (36 to 42) weeks, and mean birth weight (range) was 3075 (2268 to 4622) g. On the second day after birth, we performed echocardiography and colour-Doppler flow mapping in all subjects. BAV was classified into two types on the basis of morphologicfindings in the parasternal short axis view of the aortic valve: BAV with raphe harbouring two cusps and commissures, showing a congenital fusion of two underdeveloped cusps, and BAV without raphe, showing a fish mouth appearance in systolic images. BAV associated with other congenital heart diseases such as coarctation of the aorta was excluded from this study.
Results
BAV was identified in 14 neonates (0.09%), an incidence of 0.9 in 1,000 live births. Of the 14 BAV neonates, five had BAV with raphe, whereas nine had BAV without raphe. Of the five BAV neonates with raphe, four had fusion of the right and noncoronary cusps, whereas one had that of the right and left coronary cusps. No aortic regurgitation was detected except trivial one in only one neonate, and no significant valvar stenosis was detected.
Conclusion
The incidence of BAV in neonates was much lower than previously reported incidence data. An acquired fusion of the cusps may develop in later life, and eventually may result in increased incidence of functional BAV.
Collapse
Affiliation(s)
- K Waki
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Ueda
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Satoh
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Ogino
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Hayashi
- Kurashiki Central Hospital, Kurashiki, Japan
| | - Y Arakaki
- Kurashiki Central Hospital, Kurashiki, Japan
| |
Collapse
|
60
|
Nakagawa Y, Chinuki Y, Ueda K, Tsedendorj O, Ugajin T, Yokozeki H, Morita E. 175 Prevalence and regional differences of sensitization to galactose-α-1,3-galactose and/or cetuximab in Japan. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
61
|
Yoshida N, Fujita F, Ueda K, Ogata S, Shigaki T, Yomoda T, Ohchi T, Mizobe T, Kinugasa T, Akagi Y. Mesocolic hernia following retroperitoneal laparoscopic radical nephrectomy: A case report. Int J Surg Case Rep 2019; 61:313-317. [PMID: 31399395 PMCID: PMC6717955 DOI: 10.1016/j.ijscr.2019.07.040] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2019] [Accepted: 07/17/2019] [Indexed: 11/18/2022] Open
Abstract
An internal hernia after retroperitoneal laparoscopic nephrectomy is rare. Retroperitoneal approach has the risk of making mesocolic defects directly. To prevent internal hernia, we should close the mesenteric defects intraoperatively.
Introduction Small bowel obstruction (SBO) caused by an internal hernia through a mesocolon after retroperitoneal laparoscopic nephrectomy (RLN) is rare. Presentation of case A 66-year-old man who had undergone RLN with bladder cuff excision for a left renal pelvic cancer. After the surgery, he experienced SBO repeatedly. Contrast-enhanced computed tomography (CT) and gastrografin contract radiography through a long tube showed an internal hernia through the mesocolon to the retroperitoneal space where the resected left kidney had been located. We performed a subsequent surgery for the internal hernia. Postoperative course was uneventful and currently he has no recurrence of herniation 6 months post-operatively. Discussion Mesenteric defects that cause an internal hernia can be created inadvertently during RLN when the colon is mobilized medially, and the kidney is being detached from retroperitoneum. The removal of a kidney leads to a potential retroperitoneal space to which small intestine can migrate. While there is no absolute necessity in mobilizing the colon during the retroperitoneal laparoscopic approach, there is still a risk of making mesocolic defects directly in the retroperitoneal space. Conclusion We need to perform operations with sufficient anatomical knowledge of retroperitoneal fascia and careful surgical techniques. The critical thing to prevent an internal hernia following RLN is to close the mesenteric defects intraoperatively. It is also important to suspect an internal hernia and do proper examinations promptly when patients had the symptoms of SBO after nephrectomy.
Collapse
Affiliation(s)
- Naohiro Yoshida
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Fumihiko Fujita
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Suguru Ogata
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Takahiro Shigaki
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Takato Yomoda
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Takafumi Ohchi
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Tomoaki Mizobe
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Tetsushi Kinugasa
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| | - Yoshito Akagi
- Department of Surgery, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.
| |
Collapse
|
62
|
Kashiba A, Ueda K, Uematsu Y, Utsumi M, Miyai N, Arita M. Blood Pressure-Variation By Room Temperature In Home Pressure Among Metabolic Syndrome Using Home Blood Pressure Web-Based Monitoring. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
63
|
Khokhlova MA, Cooper B, Ueda K, Prince KC, Kolorenč P, Ivanov MY, Averbukh V. Molecular Auger Interferometry. Phys Rev Lett 2019; 122:233001. [PMID: 31298870 DOI: 10.1103/physrevlett.122.233001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Indexed: 06/10/2023]
Abstract
We introduce and present a theory of interferometric measurement of a normal Auger decay lifetime in molecules. Molecular Auger interferometry is based on the coherent phase control of Auger dynamics in a two-color (ω/2ω) laser field. We show that, in contrast to atoms, in oriented molecules of certain point groups the relative ω/2ω phase modulates the total ionization yield. A simple analytical formula is derived for the extraction of the lifetimes of Auger-active states from a molecular Auger interferogram, circumventing the need in either high-resolution or attosecond spectroscopy. We demonstrate the principle of the interferometric Auger lifetime measurement using inner-valence decay in CH_{3}F.
Collapse
Affiliation(s)
- M A Khokhlova
- Blackett Laboratory, Imperial College London, London SW7 2AZ, United Kingdom
| | - B Cooper
- Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
| | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 980-8577 Sendai, Japan
| | - K C Prince
- Elettra-Sincrotrone Trieste SCpA, 34149 Basovizza-Trieste, Italy
- Molecular Model Discovery Laboratory, Swinburne University of Technology, 3122 Hawthorn, Australia
| | - P Kolorenč
- Charles University, Institute of Theoretical Physics, V Holešovičkách 2, 180 00 Prague, Czech Republic
| | - M Yu Ivanov
- Blackett Laboratory, Imperial College London, London SW7 2AZ, United Kingdom
- Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy, Max-Born-Strasse 2A, Berlin D-12489, Germany
| | - V Averbukh
- Blackett Laboratory, Imperial College London, London SW7 2AZ, United Kingdom
| |
Collapse
|
64
|
Janakiram M, Ye H, Carjaval L, Villaorduna A, Ramesh K, Shah U, Kornblum N, Fehn K, Braunschweig I, Ueda K, Thiruthuvanathan V, Will B, Pinchasik D, Aivado M, Goel S, Steidl U, Verma A. EXCEPTIONAL RESPONSE OF REFRACTORY ATLL WITH MDM4 AMPLIFICATION TO NOVEL STAPLED PEPTIDE DUAL MDM4/2 INHIBITOR. Hematol Oncol 2019. [DOI: 10.1002/hon.210_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- M. Janakiram
- HOT; University of Minnesota; Minneapolis United States
| | - H.B. Ye
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | | | - A. Villaorduna
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - K. Ramesh
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - U. Shah
- Oncology; Memorial Sloan Kettering Cancer Center; New York United States
| | - N. Kornblum
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - K. Fehn
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - I. Braunschweig
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - K. Ueda
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | | | - B. Will
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | | | - M. Aivado
- ALRN Therapeutics; MA; United States
| | - S. Goel
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - U. Steidl
- Oncology; Albert Einstein College of Medicine; Bronx United States
| | - A.K. Verma
- Oncology; Albert Einstein College of Medicine; Bronx United States
| |
Collapse
|
65
|
Suzuki H, Gretarsson H, Ishikawa H, Ueda K, Yang Z, Liu H, Kim H, Kukusta D, Yaresko A, Minola M, Sears JA, Francoual S, Wille HC, Nuss J, Takagi H, Kim BJ, Khaliullin G, Yavaş H, Keimer B. Spin waves and spin-state transitions in a ruthenate high-temperature antiferromagnet. Nat Mater 2019; 18:563-567. [PMID: 30911120 DOI: 10.1038/s41563-019-0327-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Accepted: 02/26/2019] [Indexed: 06/09/2023]
Abstract
Ruthenium compounds serve as a platform for fundamental concepts such as spin-triplet superconductivity1, Kitaev spin liquids2-5 and solid-state analogues of the Higgs mode in particle physics6,7. However, basic questions about the electronic structure of ruthenates remain unanswered, because several key parameters (including Hund's coupling, spin-orbit coupling and exchange interactions) are comparable in magnitude and their interplay is poorly understood, partly due to difficulties in synthesizing large single crystals for spectroscopic experiments. Here we introduce a resonant inelastic X-ray scattering (RIXS)8,9 technique capable of probing collective modes in microcrystals of 4d electron materials. We observe spin waves and spin-state transitions in the honeycomb antiferromagnet SrRu2O6 (ref. 10) and use the extracted exchange interactions and measured magnon gap to explain its high Néel temperature11-16. We expect that the RIXS method presented here will enable momentum-resolved spectroscopy of a large class of 4d transition-metal compounds.
Collapse
Affiliation(s)
- H Suzuki
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany.
| | - H Gretarsson
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - H Ishikawa
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Institut für Funktionelle Materie und Quantentechnologien, Universität Stuttgart, Stuttgart, Germany
| | - K Ueda
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Department of Applied Physics, University of Tokyo, Tokyo, Japan
| | - Z Yang
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - H Liu
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - H Kim
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Department of Physics, Pohang University of Science and Technology, Pohang, South Korea
- Center for Artificial Low Dimensional Electronic Systems, Institute for Basic Science (IBS), Pohang, South Korea
| | - D Kukusta
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - A Yaresko
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - M Minola
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - J A Sears
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Francoual
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - H-C Wille
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Nuss
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - H Takagi
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Institut für Funktionelle Materie und Quantentechnologien, Universität Stuttgart, Stuttgart, Germany
- Department of Physics, University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - B J Kim
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
- Department of Physics, Pohang University of Science and Technology, Pohang, South Korea
- Center for Artificial Low Dimensional Electronic Systems, Institute for Basic Science (IBS), Pohang, South Korea
| | - G Khaliullin
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany
| | - H Yavaş
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
- SLAC National Accelerator Laboratory, Menlo Park, CA, USA
| | - B Keimer
- Max-Planck-Institut für Festkörperforschung, Stuttgart, Germany.
| |
Collapse
|
66
|
Kotoda M, Oguchi T, Mitsui K, Hishiyama S, Ueda K, Kawakami A, Matsukawa T. Removal methods of rigid stylets to minimise adverse force and tracheal tube movement: a mathematical and in-vitro analysis in manikins. Anaesthesia 2019; 74:1041-1046. [PMID: 31093966 DOI: 10.1111/anae.14699] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/15/2019] [Indexed: 11/27/2022]
Abstract
This study investigated displacement of the tracheal tube caused by different methods of intubating stylet removal, using in-vitro experiments and mathematical analysis. In the first in-vitro experiment, we measured the distance travelled by the tube tip during stylet extraction. Then, we investigated the ideal technique for stylet extraction using mathematical analysis, which would cause minimal tube displacement. Then, using a training manikin, we measured the force applied to the vocal cords and stylet extraction force during tracheal intubation. When the stylet was extracted along a straight path towards the stylet end, the distance travelled by the tube tip significantly increased as the bending angle increased. Mathematical analysis revealed that the stylet should be diagonally extracted (in the sagittal plane) at an appropriate angle, rather than along a straight path towards the direction of the stylet end. In simulated tracheal intubation, extraction force and force applied to the vocal cords both significantly increased as the bending angle increased. Compared with the 'hockey stick'-shaped stylet, the arcuate-shaped stylet resulted in reduced force. Our results indicate the potential risk for vocal cord injury when using hockey stick-shaped stylets with large bending angles.
Collapse
Affiliation(s)
- M Kotoda
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| | - T Oguchi
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| | - K Mitsui
- Surgical Center, University of Yamanashi Hospital, Yamanashi, Japan
| | - S Hishiyama
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| | - K Ueda
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| | - A Kawakami
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| | - T Matsukawa
- Department of Anesthesiology, University of Yamanashi, Yamanashi, Japan
| |
Collapse
|
67
|
Ohuchi M, Inoue S, Ozaki Y, Ueda K. Platelet count and mean platelet volume are associated with not only bone, soft tissue, and lymph node metastases but also with malignant pleural effusion in lung cancer patients. Neoplasma 2019; 64:140-147. [PMID: 27881016 DOI: 10.4149/neo_2017_118] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
An increased platelet count is often observed in lung cancer patients. Whether and how the platelets affect cancer progression have yet to be established. The aim of the study was to investigate the involvement of the platelet count and mean platelet volume (MPV) in the prognosis and progression of lung cancer patients. This retrospective study included 146 patients with newly diagnosed primary lung cancer. The platelet count and MPV were measured before invasive diagnostic procedures and treatment. These platelet indices, overall survival of the patients, and tumor metastases for each organ were analyzed. On Kaplan-Meier survival analysis, the overall survivals of patients with platelet counts ≤ 244.0 × 109/L or MPV > 9.7 fL were longer than those of patients with platelet counts > 244.0 × 109/L or MPV ≤ 9.7 fL. Cox regression analysis showed that poor performance status, increased platelet count, and increased C-reactive protein were independent prognostic factors. The platelet indices were associated with metastases to bone, soft tissue, and lymph node, in addition to malignant pleural effusion. Increased platelet count and decreased MPV were unfavorable prognostic factors for patients with lung cancer, and they were involved in bone, soft tissue, and lymph node metastases and malignant pleural effusion.
Collapse
|
68
|
Jurecki E, Ueda K, Frazier D, Rohr F, Thompson A, Hussa C, Obernolte L, Reineking B, Roberts AM, Yannicelli S, Osara Y, Stembridge A, Splett P, Singh RH. Nutrition management guideline for propionic acidemia: An evidence- and consensus-based approach. Mol Genet Metab 2019; 126:341-354. [PMID: 30879957 DOI: 10.1016/j.ymgme.2019.02.007] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2018] [Revised: 02/21/2019] [Accepted: 02/22/2019] [Indexed: 12/17/2022]
Affiliation(s)
- E Jurecki
- BioMarin Pharmaceutical Inc., Novato, CA, USA.
| | - K Ueda
- British Colombia Children's Hospital, Vancouver, BC, Canada
| | - D Frazier
- University of North Carolina, Chapel Hill, NC, USA
| | - F Rohr
- Boston Children's Hospital, Boston, MA, USA
| | - A Thompson
- Greenwood Genetic Center, Greenwood, SC, USA
| | - C Hussa
- BioMarin Pharmaceutical Inc., Novato, CA, USA
| | - L Obernolte
- Waisman Center, University of Wisconsin, Madison, WI, USA
| | - B Reineking
- BioMarin Pharmaceutical Inc., Novato, CA, USA
| | | | | | - Y Osara
- Emory University, Atlanta, GA, USA
| | | | - P Splett
- University of Minnesota, St. Paul, MN, USA
| | | |
Collapse
|
69
|
Ueda K, Ueda A, Ozaki K. Basal Cell Adenoma of the Salivary Gland and Possible Recurrence as Basal Cell Adenocarcinoma in a Black-tailed Prairie Dog (Cynomys ludovicianus). J Comp Pathol 2019; 168:13-17. [PMID: 31103053 DOI: 10.1016/j.jcpa.2019.02.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Revised: 02/07/2019] [Accepted: 02/12/2019] [Indexed: 11/18/2022]
Abstract
We describe a black-tailed prairie dog (Cynomys ludovicianus) with a benign biphasic nodular tumour that recurred as a malignant biphasic tumour at the same site 2 years after resection. Both tumours were biphasic with regard to the glandular epithelium and basal cells and contained little of the mucus, cartilage or fibrous tissue that characterize pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Both the first and second tumours exhibited histopathological features similar to those exhibited by human basal cell adenoma and adenocarcinoma, respectively. Both were resected and the animal was alive with no recurrence or metastasis at the time of writing, 9 months after the second surgery.
Collapse
Affiliation(s)
- K Ueda
- Vogel Animal Hospital, 5-1-1 Koutoku-cho, Nada-ku, Kobe, Hyogo, Japan
| | - A Ueda
- Vogel Animal Hospital, 5-1-1 Koutoku-cho, Nada-ku, Kobe, Hyogo, Japan
| | - K Ozaki
- Laboratory of Pathology, Setsunan University, 45-1 Nagaotohge-cho, Hirakata, Osaka, Japan.
| |
Collapse
|
70
|
Haghipour N, Ausin B, Usman MO, Ishikawa N, Wacker L, Welte C, Ueda K, Eglinton TI. Compound-Specific Radiocarbon Analysis by Elemental Analyzer-Accelerator Mass Spectrometry: Precision and Limitations. Anal Chem 2019; 91:2042-2049. [PMID: 30592600 DOI: 10.1021/acs.analchem.8b04491] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We examine instrumental and methodological capabilities for microscale (10-50 μg of C) radiocarbon analysis of individual compounds in the context of paleoclimate and paleoceanography applications, for which relatively high-precision measurements are required. An extensive suite of data for 14C-free and modern reference materials processed using different methods and acquired using an elemental-analyzer-accelerator-mass-spectrometry (EA-AMS) instrumental setup at ETH Zurich was compiled to assess the reproducibility of specific isolation procedures. In order to determine the precision, accuracy, and reproducibility of measurements on processed compounds, we explore the results of both reference materials and three classes of compounds (fatty acids, alkenones, and amino acids) extracted from sediment samples. We utilize a MATLAB code developed to systematically evaluate constant-contamination-model parameters, which in turn can be applied to measurements of unknown process samples. This approach is computationally reliable and can be used for any blank assessment of small-size radiocarbon samples. Our results show that a conservative lower estimate of the sample sizes required to produce relatively high-precision 14C data (i.e., with acceptable errors of <5% on final 14C ages) and high reproducibility in old samples (i.e., F14C ≈ 0.1) using current isolation methods are 50 and 30 μg of C for alkenones and fatty acids, respectively. Moreover, when the F14C is >0.5, a precision of 2% can be achieved for alkenone and fatty acid samples containing ≥15 and 10 μg of C, respectively.
Collapse
Affiliation(s)
- N Haghipour
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland.,Laboratory of Ion Beam Physics , ETHZ , Otto-Stern-Weg 5 , 8093 Zurich , Switzerland
| | - B Ausin
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland
| | - M O Usman
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland
| | - N Ishikawa
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland.,Department of Biogeochemistry , Japan Agency for Marine-Earth Science and Technology , 237-0061 Yokosuka , Japan
| | - L Wacker
- Laboratory of Ion Beam Physics , ETHZ , Otto-Stern-Weg 5 , 8093 Zurich , Switzerland
| | - C Welte
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland.,Laboratory of Ion Beam Physics , ETHZ , Otto-Stern-Weg 5 , 8093 Zurich , Switzerland
| | - K Ueda
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland
| | - T I Eglinton
- Geological Institute , ETHZ , Sonneggstrasse 5 , 8092 Zurich , Switzerland
| |
Collapse
|
71
|
Kurose H, Naito Y, Akiba J, Kondo R, Ogasawara S, Kusano H, Sanada S, Abe H, Kakuma T, Ueda K, Igawa T, Yano H. High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer. Med Mol Morphol 2019; 52:164-172. [PMID: 30631948 DOI: 10.1007/s00795-018-00214-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Accepted: 11/21/2018] [Indexed: 12/13/2022]
Abstract
Sulfite oxidase (SUOX) is a metalloenzyme that plays a role in ATP synthesis via oxidative phosphorylation in mitochondria and has been reported to also be involved in the invasion and differentiation capacities of tumor cells. Here, we performed a clinicopathological investigation of SUOX expression in prostate cancer and discussed the usefulness of SUOX expression as a predictor of biochemical recurrence following surgical treatment in prostate cancer. This study was conducted using Tissue Micro Array specimens obtained from 97 patients who underwent radical prostatectomy at our hospital between 2007 and 2011. SUOX staining was used to evaluate cytoplasmic SUOX expression. In the high-expression group, the early biochemical recurrence was significantly more frequent than in the low-expression group (p = 0.0008). In multivariate analysis, high SUOX expression was found to serve as an independent prognostic factor of biochemical recurrence (hazard ratio = 2.33, 95% confidence interval = 1.32-4.15, p = 0.0037). In addition, Ki-67-labeling indices were significantly higher in the high-expression group than in the low-expression group (p = 0.0058). Therefore, SUOX expression may be a powerful prognostic biomarker for decision-making in postoperative follow-up after total prostatectomy and with regard to the need for relief treatment.
Collapse
Affiliation(s)
- Hirofumi Kurose
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.,Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Yoshiki Naito
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. .,Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.
| | - Jun Akiba
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Reiichiro Kondo
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan
| | - Sachiko Ogasawara
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan
| | - Hironori Kusano
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan
| | - Sakiko Sanada
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan
| | - Hideyuki Abe
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Tatsuyuki Kakuma
- Biostatistics Center, Kurume University School of Medicine, Kurume, Japan
| | - Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Hirohisa Yano
- Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan
| |
Collapse
|
72
|
Saito Y, Harada S, Kobayashi M, Ueda K, Yamazaki K, Kumai M, Miyamoto T, Kasashi K, Yamada T, Komatsu Y, Iseki K. [Survey of the Efficacy of Long-term and Successive Pharmaceutical Care in Outpatient Chemotherapy by Oncology Pharmacy Specialists]. YAKUGAKU ZASSHI 2018; 138:1409-1416. [PMID: 30381649 DOI: 10.1248/yakushi.18-00081] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
It is important that pharmacists ensure safe chemotherapy implementation. In addition to inspecting chemotherapeutic prescriptions according to patient condition and drug-drug interactions, the management of chemotherapy-induced adverse effects and associated pharmaceutical intervention is one of the most important responsibilities of pharmacists in medical care teams. In May 2016, an oncology pharmacist was set responsible for the specialized, long-term, and successive pharmaceutical care, including instructions about appropriate use of medication at an outpatient chemotherapy center. We evaluated the effectiveness of the continuous pharmaceutical care. The number of medication counseling and associated pharmaceutical interventions increased with time. Specifically, the number of pharmaceutical interventions (prescription questions and pharmaceutical proposals) was 745 (459 and 286, respectively) in the surveillance period, which significantly increased compared to that observed within the same duration before posting an oncology pharmacist. The adoption rate was approximately 70% for prescription questions and 98% for pharmaceutical proposals. We also found that approximately 70% of the proposals attenuated the painful symptoms. Furthermore, approximately 60% of all pharmaceutical interventions were established after the third visit; in particular, approximately 20% of the pharmaceutical proposals were suggested after the sixth visit, indicating that continuous medication counseling results in an increase in pharmaceutical proposals. In conclusion, long-term and successive pharmaceutical care by oncology pharmacy specialists in outpatient chemotherapy contributes to a safe and less onerous chemotherapy implementation, as it has been highly adopted, is effective in many cases, and has been proven to be important for risk management in chemotherapy.
Collapse
Affiliation(s)
| | | | | | - Kosuke Ueda
- Department of Pharmacy, Hokkaido University Hospital
| | | | | | | | | | | | | | - Ken Iseki
- Department of Pharmacy, Hokkaido University Hospital.,Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University
| |
Collapse
|
73
|
Suzuki A, Segawa T, Sawa S, Nishitani C, Ueda K, Itou T, Asahina K, Suzuki M. Comparison of the gut microbiota of captive common bottlenose dolphins Tursiops truncatus
in three aquaria. J Appl Microbiol 2018; 126:31-39. [DOI: 10.1111/jam.14109] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Revised: 09/06/2018] [Accepted: 09/11/2018] [Indexed: 01/21/2023]
Affiliation(s)
- A. Suzuki
- Graduate School of Bioresource Sciences; Nihon University; Fujisawa Kanagawa Japan
| | - T. Segawa
- Graduate School of Bioresource Sciences; Nihon University; Fujisawa Kanagawa Japan
- Cetacean Research Center; Graduate School of Bioresources, Mie University; Tsu Mie Japan
| | - S. Sawa
- Tsukumi Dolphin Island; Tsukimi Oita Japan
| | | | - K. Ueda
- Okinawa Churashima Foundation; Motobu, Kunigami Okinawa Japan
| | - T. Itou
- Nihon University Veterinary Research Center; College of Bioresource Sciences, Nihon University; Fujisawa Kanagawa Japan
| | - K. Asahina
- Graduate School of Bioresource Sciences; Nihon University; Fujisawa Kanagawa Japan
| | - M. Suzuki
- Graduate School of Bioresource Sciences; Nihon University; Fujisawa Kanagawa Japan
| |
Collapse
|
74
|
Tanaka T, Ueda K, Murakami J, Nakamura T, Yoshimine S, Hamano K. P1.11-14 Radiological Pleura-Tumor Proximity in Pure-Solid Clinical Stage I Lung Cancer: Its Influence on Lymph Node Metastasis and Recurrence. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
75
|
Alonso-Mori R, Asa K, Bergmann U, Brewster AS, Chatterjee R, Cooper JK, Frei HM, Fuller FD, Goggins E, Gul S, Fukuzawa H, Iablonskyi D, Ibrahim M, Katayama T, Kroll T, Kumagai Y, McClure BA, Messinger J, Motomura K, Nagaya K, Nishiyama T, Saracini C, Sato Y, Sauter NK, Sokaras D, Takanashi T, Togashi T, Ueda K, Weare WW, Weng TC, Yabashi M, Yachandra VK, Young ID, Zouni A, Kern JF, Yano J. Towards characterization of photo-excited electron transfer and catalysis in natural and artificial systems using XFELs. Faraday Discuss 2018; 194:621-638. [PMID: 27711803 DOI: 10.1039/c6fd00084c] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The ultra-bright femtosecond X-ray pulses provided by X-ray Free Electron Lasers (XFELs) open capabilities for studying the structure and dynamics of a wide variety of biological and inorganic systems beyond what is possible at synchrotron sources. Although the structure and chemistry at the catalytic sites have been studied intensively in both biological and inorganic systems, a full understanding of the atomic-scale chemistry requires new approaches beyond the steady state X-ray crystallography and X-ray spectroscopy at cryogenic temperatures. Following the dynamic changes in the geometric and electronic structure at ambient conditions, while overcoming X-ray damage to the redox active catalytic center, is key for deriving reaction mechanisms. Such studies become possible by using the intense and ultra-short femtosecond X-ray pulses from an XFEL, where sample is probed before it is damaged. We have developed methodology for simultaneously collecting X-ray diffraction data and X-ray emission spectra, using an energy dispersive spectrometer, at ambient conditions, and used this approach to study the room temperature structure and intermediate states of the photosynthetic water oxidizing metallo-protein, photosystem II. Moreover, we have also used this setup to simultaneously collect the X-ray emission spectra from multiple metals to follow the ultrafast dynamics of light-induced charge transfer between multiple metal sites. A Mn-Ti containing system was studied at an XFEL to demonstrate the efficacy and potential of this method.
Collapse
Affiliation(s)
- R Alonso-Mori
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - K Asa
- Department of Physics, Graduate School of Science, Kyoto U., Kyoto, 606-8502, Japan
| | - U Bergmann
- Stanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - A S Brewster
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - R Chatterjee
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - J K Cooper
- Joint Center for Artificial Photosynthesis (JCAP), Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA
| | - H M Frei
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - F D Fuller
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - E Goggins
- Dept. of Chemistry, North Carolina State University, 2620 Yarborough Rd., Raleigh, NC 27695-8204, USA
| | - S Gul
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - H Fukuzawa
- IMRAM, Tohoku U., Sendai 980-8577, Japan and RIKEN SPring-8 Center, Kouto, Sayo, Hyogo 679-5148, Japan
| | | | - M Ibrahim
- Institut für Biologie, Humboldt-Universität zu Berlin, D-10099 Berlin, Germany
| | - T Katayama
- Japan Synchrotron Radiation Research Institute (JASRI), SPring-8/SACLA, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan
| | - T Kroll
- Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Y Kumagai
- IMRAM, Tohoku U., Sendai 980-8577, Japan
| | - B A McClure
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - J Messinger
- Institutionen för Kemi, Kemiskt Biologiskt Centrum, Umeå Universitet, Umeå, Sweden
| | - K Motomura
- IMRAM, Tohoku U., Sendai 980-8577, Japan and RIKEN SPring-8 Center, Kouto, Sayo, Hyogo 679-5148, Japan
| | - K Nagaya
- Department of Physics, Graduate School of Science, Kyoto U., Kyoto, 606-8502, Japan and RIKEN SPring-8 Center, Kouto, Sayo, Hyogo 679-5148, Japan
| | - T Nishiyama
- Department of Physics, Graduate School of Science, Kyoto U., Kyoto, 606-8502, Japan
| | - C Saracini
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - Y Sato
- Department of Physics, Graduate School of Science, Kyoto U., Kyoto, 606-8502, Japan
| | - N K Sauter
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - D Sokaras
- Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | | | - T Togashi
- Japan Synchrotron Radiation Research Institute (JASRI), SPring-8/SACLA, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan
| | - K Ueda
- IMRAM, Tohoku U., Sendai 980-8577, Japan and RIKEN SPring-8 Center, Kouto, Sayo, Hyogo 679-5148, Japan
| | - W W Weare
- Dept. of Chemistry, North Carolina State University, 2620 Yarborough Rd., Raleigh, NC 27695-8204, USA
| | - T-C Weng
- Center for High Pressure Science & Technology Advanced Research, Shanghai, China
| | - M Yabashi
- Japan Synchrotron Radiation Research Institute (JASRI), SPring-8/SACLA, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan
| | - V K Yachandra
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - I D Young
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - A Zouni
- Institut für Biologie, Humboldt-Universität zu Berlin, D-10099 Berlin, Germany
| | - J F Kern
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA and Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA.
| | - J Yano
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA. and Joint Center for Artificial Photosynthesis (JCAP), Lawrence Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley, CA 94720, USA and IMRAM, Tohoku U., Sendai 980-8577, Japan
| |
Collapse
|
76
|
Ueda K, Suekane S, Hirano T, Ogasawara N, Chikui K, Uemura K, Nakiri M, Nishihara K, Matsuo M, Igawa T. Efficacy of Axitinib as Second-line Treatment in Locally Advanced and Metastatic Renal Cell Carcinoma. Anticancer Res 2018; 38:5387-5392. [PMID: 30194193 DOI: 10.21873/anticanres.12868] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 07/26/2018] [Accepted: 07/27/2018] [Indexed: 11/10/2022]
Abstract
AIM To investigate prognostic factors for patients with advanced renal cell carcinoma (RCC) treated with axitinib as second-line therapy. PATIENTS AND METHODS This study included 35 patients with RCC who received axitinib as second-line therapy after the failure of first-line tyrosine kinases inhibitor from November 2012 to March 2017. RESULTS In univariate analyses, the following factors were associated with poor prognosis: bone and extrapulmonary metastasis for progression-free survival; and prior nephrectomy, Memorial Sloan Kettering Cancer Center risk classification, International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk classification of poor, extrapulmonary metastasis and early tumor response for overall survival. Multivariate analyses identified the following factors as independent poor prognostic effects: extrapulmonary metastasis for progression-free survival, and no prior nephrectomy, IMDC risk classification of poor and extrapulmonary metastasis for overall survival. CONCLUSION Axitinib as second-line treatment is effective for patients with pulmonary metastasis alone of RCC, but not for those with extrapulmonary metastasis.
Collapse
Affiliation(s)
- Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Shigetaka Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Taishi Hirano
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Naoyuki Ogasawara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Katsuaki Chikui
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Keiichiro Uemura
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Mitsunori Matsuo
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| |
Collapse
|
77
|
Suehiro K, Morikage N, Ueda K, Samura M, Takeuchi Y, Nagase T. Venous Hemodynamics Assessed With Air Plethysmography in Legs With Lymphedema. J Vasc Surg Venous Lymphat Disord 2018. [DOI: 10.1016/j.jvsv.2018.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
78
|
Tanaka N, Kunihiro Y, Kubo M, Kawano R, Oishi K, Ueda K, Gondo T. HRCT findings of collagen vascular disease-related interstitial pneumonia (CVD-IP): a comparative study among individual underlying diseases. Clin Radiol 2018; 73:833.e1-833.e10. [DOI: 10.1016/j.crad.2018.04.017] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 04/23/2018] [Indexed: 01/14/2023]
|
79
|
Ueda K, Watanabe A, Yokoi N, Sugimoto M, Fukuoka H, Shinomiya K, Kinoshita S, Rajak S, Selva D. Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy. Orbit 2018; 38:37-42. [PMID: 30142018 DOI: 10.1080/01676830.2018.1513536] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
PURPOSE The purpose of this article is to present a novel technique, as well the histopathological findings, of dacryoendoscopic guided nasolacrimal duct (NLD) biopsy for recurrent nasolacrimal duct obstruction (NLDO). METHODS This study involved subjects with recurrent NLDO. Direct endoscopic probing or sheath-guided endoscopic probing was used for the initial intubation in all treated eyes, and the stent had been removed at between 2 and 11 months (mean 3.5 months) post-intubation with dacryoendoscopic confirmation of patency and mucosal regeneration. Biopsy specimens were obtained by scraping the recurrent lesion by sheath advancement. Histopathological examination and immunohistochemical (IHC) staining were performed. RESULTS In five patients (two males and three females, mean age: 71.2 ± 5.6 years [range: 61-78 years]) with recurrent NLDO, biopsy specimens were obtained from six ducts of six eyes, and stratified epithelium and a mixed inflammatory cell infiltrates were identified. IHC staining was positive for cytokeratin (CK)4 and CK13, and negative for paired box protein Pax-6. CONCLUSIONS This novel technique enabled a minimally invasive biopsy of the NLD to be obtained, and IHC staining indicated the presence of mucus epithelium, thus suggesting squamous metaplasia of the usual respiratory epithelium which likely occurs secondary to chronic inflammation.
Collapse
Affiliation(s)
- Kosuke Ueda
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | - Akihide Watanabe
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | - Norihiko Yokoi
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | | | - Hideki Fukuoka
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | - Katsuhiko Shinomiya
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | - Shigeru Kinoshita
- a Department of Ophthalmology , Kyoto Prefectural University of Medicine , Kyoto , Japan
| | - Saul Rajak
- c Sussex Eye Hospital , Brighton and Sussex University Hospital , Brighton , United Kingdom
| | - Dinesh Selva
- d Discipline of Ophthalmology and Visual Sciences , South Australian Institute of Ophthalmology and Royal Adelaide Hospital , Adelaide , Australia
| |
Collapse
|
80
|
Ueda K, Suekane S, Kurose H, Chikui K, Nakiri M, Nishihara K, Matsuo M, Kawahara A, Yano H, Igawa T. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma. Urol Oncol 2018; 36:499.e9-499.e16. [PMID: 30131293 DOI: 10.1016/j.urolonc.2018.07.003] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 05/14/2018] [Accepted: 07/10/2018] [Indexed: 01/08/2023]
Abstract
OBJECTIVE In renal cell carcinoma (RCC), several prognostic biomarkers have been identified and are under investigation. Several reports have shown that the expression of programmed death 1 (PD-1) and its ligand PD-L1 is associated with poor outcome for patients with RCC. The present study is aimed at evaluating the expression of PD-1 and PD-L1 and to investigate their clinical and prognostic significance in patients with clear cell RCC (CCRCC) having received molecular targeted therapies. In addition, we also evaluated the relationship between the expression of PD-1 and PD-L1 and intratumoral tumor infiltrating lymphocytes (TILs). METHODS A total of 33 patients with metastatic CCRCC who underwent surgery and received molecular targeted therapies from March 2008 to April 2016 were retrospectively reviewed and analyzed. Tissue specimens from the patients were analyzed for PD-1 and PD-L1 expression by immunohistochemistry. RESULTS The median patient age was 64 years old (range=53-78). The majority of patients were male (81.8%). All Memorial Sloan Kettering Cancer Center risk groups were represented among the patients with 39.4% with favorable-, 51.5% with intermediate- and 9.1% with poor-risk. The expression of PD-1 and PD-L1 was observed in 16 (48.5%) and 9 (27.3%) patients, respectively. The expression of PD-1 and PD-L1 was associated with a larger primary renal tumor size, higher nuclear grade and sarcomatoid feature. Kaplan-Meier analysis revealed that no significant difference in progression free survival of first line molecular targeted therapy was found for PD-1 (P=0.2396) and PD-L1 (P=0.5919) expression. However, PD-1 expression has a significant worse impact on overall survival (OS) (P=0.0385), while for PD-L1 expression only a trend is seen for OS (P=0.1542). The patients with PD-1 and PD-L1 expression showed higher infiltration of CD4 (P<0.0001 and P<0.0001, respectively), CD8 (P=0.0328 and P=0.0044, respectively) and FOXP3 (P<0.0001 and P=0.0033, respectively) positive TILs. CONCLUSION PD-1 and PD-L1 expression is significantly associated with adverse clinicopathological features in CCRCC. Furthermore, PD-1 expression could be one of the biomarkers suggesting poor outcome in patients with metastatic CCRCC receiving molecular targeted therapies.
Collapse
Affiliation(s)
- Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Japan.
| | - Shigetaka Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Hirofumi Kurose
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Katsuaki Chikui
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Mitsunori Matsuo
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| | - Akihiko Kawahara
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Hirohisa Yano
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Japan
| |
Collapse
|
81
|
Kukk E, Thomas TD, Céolin D, Granroth S, Travnikova O, Berholts M, Marchenko T, Guillemin R, Journel L, Ismail I, Püttner R, Piancastelli MN, Ueda K, Simon M. Energy Transfer into Molecular Vibrations and Rotations by Recoil in Inner-Shell Photoemission. Phys Rev Lett 2018; 121:073002. [PMID: 30169107 DOI: 10.1103/physrevlett.121.073002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2018] [Indexed: 06/08/2023]
Abstract
A mixture of CF_{4} and CO gases is used to study photoelectron recoil effects extending into the tender x-ray region. In CF_{4}, the vibrational envelope of the C 1s photoelectron spectrum becomes fully dominated by the recoil-induced excitations, revealing vibrational modes hidden from Franck-Condon excitations. In CO, using CF_{4} as an accurate energy calibrant, we determine the partitioning of the recoil-induced internal excitation energy between rotational and vibrational excitation. The observed rotational recoil energy is 2.88(28) times larger than the observed vibrational recoil energy, well in excess of the ratio of 2 predicted by the basic recoil model. The experiment is, however, in good agreement with the value of 2.68 if energy transfer via Coriolis coupling is included.
Collapse
Affiliation(s)
- E Kukk
- Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - T D Thomas
- Department of Chemistry, Oregon State University, Corvallis, Oregon 97331, USA
| | - D Céolin
- Synchrotron SOLEIL, L'Orme des Merisiers, Saint-Aubin, B.P. 48, FR-91192 Gif-sur-Yvette Cedex, France
| | - S Granroth
- Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - O Travnikova
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| | - M Berholts
- Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
- Department of Physics, University of Tartu, EST-50411 Tartu, Estonia
| | - T Marchenko
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| | - R Guillemin
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| | - L Journel
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| | - I Ismail
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| | - R Püttner
- Fachbereich Physik, Freie Universität Berlin, Arnimallee 14, D-14195 Berlin-Dahlem, Germany
| | - M N Piancastelli
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
- Department of Physics and Astronomy, Uppsala University, SE-75120 Uppsala, Sweden
| | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - M Simon
- Synchrotron SOLEIL, L'Orme des Merisiers, Saint-Aubin, B.P. 48, FR-91192 Gif-sur-Yvette Cedex, France
- Sorbonne Université, CNRS, Laboratoire de Chimie Physique-Matière et Rayonnement, LCPMR, F-75005 Paris, France
| |
Collapse
|
82
|
Kawamura J, Ueda K, Ushijima H, Daito K, Okuno K. Transanal minimally invasive approach for the resection of retrorectal tumour - a video vignette. Colorectal Dis 2018; 20:646-647. [PMID: 29694696 DOI: 10.1111/codi.14236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Accepted: 04/09/2018] [Indexed: 02/08/2023]
Affiliation(s)
- J Kawamura
- Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan
| | - K Ueda
- Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan
| | - H Ushijima
- Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan
| | - K Daito
- Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan
| | - K Okuno
- Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan
| |
Collapse
|
83
|
Tsedendorj O, Chinuki Y, Ueda K, Yamasaki K, Kikuchi K, Ito Y, Aiba S, Morita E. 249 Different prevalence of sensitization against galactose--1,3-galactose between Shimane and Miyagi in Japan. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
84
|
Suehiro K, Morikage N, Ueda K, Samura M, Takeuchi Y, Nagase T, Mizoguchi T, Hamano K. Peculiar clinical features of cellulitis in peripheral lymphedema. Lymphology 2018; 51:47-53. [PMID: 30253454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Although the occurrence of cellulitis in lymphedema (LE) is believed to be an infection-related event, many findings in its clinical course seem to suggest that it is unlikely to be an infection. Therefore, we tried to clarify the specific features of cellulitis in LE. In-hospital courses of cellulitis obtained from medical charts were reviewed in the patients with leg LE (LE; 24 patients, 72admissions), chronic venous insufficiency (CVI; 28 patients, 29 admissions), and leg cellulitis secondary to wound infection without underlying disease (N; 42 patients, 42 admissions). The patients with LE complained of less local pain (peak numerical scale; LE: 1.4 ± 1.7, CVI: 4.1 ± 2.5, N: 3.2 ±2.0, p < 0.0001), showed an abnormally higher peak procalcitonin level (LE: 33.8 ± 34.8 (N = 7), CVI: 2.9 ± 5.8 (N = 8), N: 0.4 ± 0.6(N = 10), p < 0.05), and required fewer antibiotics (LE: 1.1 ± 0.3, CVI: 1.8 ± 0.9, N: 1.5 ± 0.9, p < 0.0001). These findings suggested that the occurrence of cellulitis in LE seems unlikely to be an infection-related type of cellulitis similar to that found in CVI.
Collapse
Affiliation(s)
- K Suehiro
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - N Morikage
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - K Ueda
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - M Samura
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - Y Takeuchi
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - T Nagase
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - T Mizoguchi
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| | - K Hamano
- Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
| |
Collapse
|
85
|
Seddon EA, Clarke JA, Dunning DJ, Masciovecchio C, Milne CJ, Parmigiani F, Rugg D, Spence JCH, Thompson NR, Ueda K, Vinko SM, Wark JS, Wurth W. Short-wavelength free-electron laser sources and science: a review. Rep Prog Phys 2017; 80:115901. [PMID: 29059048 DOI: 10.1088/1361-6633/aa7cca] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
This review is focused on free-electron lasers (FELs) in the hard to soft x-ray regime. The aim is to provide newcomers to the area with insights into: the basic physics of FELs, the qualities of the radiation they produce, the challenges of transmitting that radiation to end users and the diversity of current scientific applications. Initial consideration is given to FEL theory in order to provide the foundation for discussion of FEL output properties and the technical challenges of short-wavelength FELs. This is followed by an overview of existing x-ray FEL facilities, future facilities and FEL frontiers. To provide a context for information in the above sections, a detailed comparison of the photon pulse characteristics of FEL sources with those of other sources of high brightness x-rays is made. A brief summary of FEL beamline design and photon diagnostics then precedes an overview of FEL scientific applications. Recent highlights are covered in sections on structural biology, atomic and molecular physics, photochemistry, non-linear spectroscopy, shock physics, solid density plasmas. A short industrial perspective is also included to emphasise potential in this area.
Collapse
Affiliation(s)
- E A Seddon
- ASTeC, STFC Daresbury Laboratory, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Cheshire, WA4 4AD, United Kingdom. The School of Physics and Astronomy and Photon Science Institute, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom. The Cockcroft Institute, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Cheshire, WA4 4AD, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
86
|
Tsutani Y, Miyata Y, Masuda T, Fujitaka K, Doi M, Awaya Y, Kuyama S, Kitaguchi S, Ueda K, Okada M. Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx671.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
87
|
Teramoto K, Namura Y, Hayashi K, Ishida K, Ueda K, Okamoto K, Kaku R, Hori T, Kawaguchi Y, Igarashi T, Hashimoto M, Ohshio Y, Kitamura S, Motoishi M, Suzumura Y, Sawai S, Hanaoka J, Daigo Y. P1.03-037 A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
88
|
Hanada S, Van Winkle MT, Subramani S, Ueda K. Dynamic ultrasound-guided short-axis needle tip navigation technique vs. landmark technique for difficult saphenous vein access in children: a randomised study. Anaesthesia 2017; 72:1508-1515. [DOI: 10.1111/anae.14082] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/30/2017] [Indexed: 12/29/2022]
Affiliation(s)
- S. Hanada
- Department of Anesthesia; University of Iowa Hospitals and Clinics; Iowa City IA USA
| | | | - S. Subramani
- Department of Anesthesia; University of Iowa Hospitals and Clinics; Iowa City IA USA
| | - K. Ueda
- Department of Anesthesia; University of Iowa Hospitals and Clinics; Iowa City IA USA
| |
Collapse
|
89
|
Ueda K, Reed C, Lebrec J, Dell’Agnello G. Real-world Alzheimer’s disease drug treatment – 18-month results from an observational study in three European countries (GERAS; encore from 2016 EAN). J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
90
|
Takeuchi T, Kanai M, Ueda K, Takafuji K, Sakai S, Nagai Y. Induction of exosome secretion and its proteomic changes in the polyglutamine disease models. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
91
|
Epp SW, Hada M, Zhong Y, Kumagai Y, Motomura K, Mizote S, Ono T, Owada S, Axford D, Bakhtiarzadeh S, Fukuzawa H, Hayashi Y, Katayama T, Marx A, Müller-Werkmeister HM, Owen RL, Sherrell DA, Tono K, Ueda K, Westermeier F, Miller RJD. Time zero determination for FEL pump-probe studies based on ultrafast melting of bismuth. Struct Dyn 2017; 4:054308. [PMID: 29152535 PMCID: PMC5658228 DOI: 10.1063/1.4999701] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2017] [Accepted: 10/11/2017] [Indexed: 05/18/2023]
Abstract
A common challenge for pump-probe studies of structural dynamics at X-ray free-electron lasers (XFELs) is the determination of time zero (T0)-the time an optical pulse (e.g., an optical laser) arrives coincidently with the probe pulse (e.g., a XFEL pulse) at the sample position. In some cases, T0 might be extracted from the structural dynamics of the sample's observed response itself, but generally, an independent robust method is required or would be superior to the inferred determination of T0. In this paper, we present how the structural dynamics in ultrafast melting of bismuth can be exploited for a quickly performed, reliable and accurate determination of T0 with a precision below 20 fs and an overall experimental accuracy of 50 fs to 150 fs (estimated). Our approach is potentially useful and applicable for fixed-target XFEL experiments, such as serial femtosecond crystallography, utilizing an optical pump pulse in the ultraviolet to near infrared spectral range and a pixelated 2D photon detector for recording crystallographic diffraction patterns in transmission geometry. In comparison to many other suitable approaches, our method is fairly independent of the pumping wavelength (UV-IR) as well as of the X-ray energy and offers a favorable signal contrast. The technique is exploitable not only for the determination of temporal characteristics of the experiment at the interaction point but also for investigating important conditions affecting experimental control such as spatial overlap and beam spot sizes.
Collapse
Affiliation(s)
- S W Epp
- Max Planck Institute for the Structure and Dynamics of Matter, 22761 Hamburg, Germany
| | - M Hada
- Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan
| | - Y Zhong
- Max Planck Institute for the Structure and Dynamics of Matter, 22761 Hamburg, Germany
| | - Y Kumagai
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - K Motomura
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - S Mizote
- Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan
| | - T Ono
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - S Owada
- RIKEN SPring-8 Center, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan
| | - D Axford
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom
| | | | - H Fukuzawa
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - Y Hayashi
- Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan
| | | | - A Marx
- Max Planck Institute for the Structure and Dynamics of Matter, 22761 Hamburg, Germany
| | | | - R L Owen
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom
| | - D A Sherrell
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom
| | | | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - F Westermeier
- Max Planck Institute for the Structure and Dynamics of Matter, 22761 Hamburg, Germany
| | | |
Collapse
|
92
|
Iablonskyi D, Ueda K, Ishikawa KL, Kheifets AS, Carpeggiani P, Reduzzi M, Ahmadi H, Comby A, Sansone G, Csizmadia T, Kuehn S, Ovcharenko E, Mazza T, Meyer M, Fischer A, Callegari C, Plekan O, Finetti P, Allaria E, Ferrari E, Roussel E, Gauthier D, Giannessi L, Prince KC. Observation and Control of Laser-Enabled Auger Decay. Phys Rev Lett 2017; 119:073203. [PMID: 28949652 DOI: 10.1103/physrevlett.119.073203] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Indexed: 06/07/2023]
Abstract
Single-photon laser-enabled Auger decay (spLEAD) is predicted theoretically [B. Cooper and V. Averbukh, Phys. Rev. Lett. 111, 083004 (2013)PRLTAO0031-900710.1103/PhysRevLett.111.083004] and here we report its first experimental observation in neon. Using coherent, bichromatic free-electron laser pulses, we detect the process and coherently control the angular distribution of the emitted electrons by varying the phase difference between the two laser fields. Since spLEAD is highly sensitive to electron correlation, this is a promising method for probing both correlation and ultrafast hole migration in more complex systems.
Collapse
Affiliation(s)
- D Iablonskyi
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - K L Ishikawa
- Department of Nuclear Engineering and Management, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan
- Photon Science Center, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan
| | - A S Kheifets
- Research School of Physics and Engineering, Australian National University, Canberra, ACT 2601, Australia
| | - P Carpeggiani
- Dipartimento di Fisica, CNR-IFN, Politecnico di Milano, 20133 Milan, Italy
| | - M Reduzzi
- Dipartimento di Fisica, CNR-IFN, Politecnico di Milano, 20133 Milan, Italy
| | - H Ahmadi
- Dipartimento di Fisica, CNR-IFN, Politecnico di Milano, 20133 Milan, Italy
| | - A Comby
- Dipartimento di Fisica, CNR-IFN, Politecnico di Milano, 20133 Milan, Italy
| | - G Sansone
- Dipartimento di Fisica, CNR-IFN, Politecnico di Milano, 20133 Milan, Italy
- Physikalisches Institut der Albert-Ludwigs-Universitat, 79104 Freiburg, Germany
| | - T Csizmadia
- ELI-ALPS, Pintér József utca, 6728 Szeged, Hungary
| | - S Kuehn
- ELI-ALPS, Pintér József utca, 6728 Szeged, Hungary
| | | | - T Mazza
- European XFEL GmbH, 22869 Schenefeld, Germany
| | - M Meyer
- European XFEL GmbH, 22869 Schenefeld, Germany
| | - A Fischer
- Max Planck Institute for Nuclear Physics, Heidelberg 69117, Germany
| | - C Callegari
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - O Plekan
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - P Finetti
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - E Allaria
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - E Ferrari
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - E Roussel
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - D Gauthier
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
| | - L Giannessi
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
- ENEA C.R. Frascati, 00044 Frascati, Rome, Italy
| | - K C Prince
- Elettra-Sincrotrone Trieste, 34149 Basovizza, Trieste, Italy
- Molecular Model Discovery Laboratory, Department of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne 3122, Australia
| |
Collapse
|
93
|
Tone T, Fujisawa N, Seki Y, Iida H, Tachikawa K, Sugihara M, Minato A, Nishio S, Yamamoto T, Kitamura K, Ueda K, Saito S, Shimada R, Matsuda Y, Naruse Y, Shimamoto S, Tamura S, Yoshikawa M, Tomabechi K. Conceptual Design of Fusion Experimental Reactor(FER). ACTA ACUST UNITED AC 2017. [DOI: 10.13182/fst83-a22924] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Tone
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - N. Fujisawa
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - Y. Seki
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - H. Iida
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - K. Tachikawa
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - M. Sugihara
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - A. Minato
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - S. Nishio
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - T. Yamamoto
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - K. Kitamura
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - K. Ueda
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - S. Saito
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - R. Shimada
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - Y. Matsuda
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - Y. Naruse
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - S. Shimamoto
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - S. Tamura
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - M. Yoshikawa
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| | - K. Tomabechi
- Japan Atomic Energy Research Institute Naka-machi, Naka-gun, Ibaraki-ken, Japan (02929) 5-3111
| |
Collapse
|
94
|
Ueda K, Suekane S, Nishihara K, Suekane H, Ogasawara N, Kurose H, Chikui K, Ejima K, Suyama S, Nakiri M, Matsuo M, Igawa T. Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies. Mol Clin Oncol 2017; 7:205-210. [PMID: 28781786 DOI: 10.3892/mco.2017.1294] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 04/13/2017] [Indexed: 11/06/2022] Open
Abstract
The aim of the present study was to investigate the prognostic factors for patients with primary unresectable renal cell carcinoma (RCC) with synchronous distant metastasis receiving molecularly targeted therapies. A total of 26 patients with primary unresectable RCC with synchronous distant metastasis underwent molecularly targeted therapies at the Kurume University Hospital (Kurume, Japan) between March 2008 and March 2016. Early primary renal tumor response was evaluated at 8-12 weeks after the introduction of molecularly targeted therapy and a 10% decrease in the diameter of primary renal tumor was used as the cut-off value. The median overall survival from the initiation of first-line molecularly targeted therapy was 18.3 months. Univariate analyses for various factors identified early primary renal tumor response (P=0.0004) and best response to first-line treatment (P=0.0002) as prognostic variables. Multivariate analyses also identified early primary renal tumor response (P=0.0099) and best response to first-line treatment (P=0.0054) as independent prognostic factors. A comparison of clinical characteristics between the group with ≥10% shrinkage and the group with disease progression or <10% shrinkage revealed that the number of metastatic sites and pretreatment monocyte-to-lymphocyte ratio tended to be predictive factors for primary renal tumor response. These results suggest that early primary renal tumor shrinkage is highly variable for patients with primary unresectable RCC with synchronous distant metastasis receiving molecularly targeted therapies.
Collapse
Affiliation(s)
- Kosuke Ueda
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Shigetaka Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Kiyoaki Nishihara
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Hiroki Suekane
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Naoyuki Ogasawara
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Hirofumi Kurose
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Katsuaki Chikui
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Kazuhisa Ejima
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Shunsuke Suyama
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Makoto Nakiri
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Mitsunori Matsuo
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| |
Collapse
|
95
|
Sanchez-Gonzalez A, Micaelli P, Olivier C, Barillot TR, Ilchen M, Lutman AA, Marinelli A, Maxwell T, Achner A, Agåker M, Berrah N, Bostedt C, Bozek JD, Buck J, Bucksbaum PH, Montero SC, Cooper B, Cryan JP, Dong M, Feifel R, Frasinski LJ, Fukuzawa H, Galler A, Hartmann G, Hartmann N, Helml W, Johnson AS, Knie A, Lindahl AO, Liu J, Motomura K, Mucke M, O'Grady C, Rubensson JE, Simpson ER, Squibb RJ, Såthe C, Ueda K, Vacher M, Walke DJ, Zhaunerchyk V, Coffee RN, Marangos JP. Accurate prediction of X-ray pulse properties from a free-electron laser using machine learning. Nat Commun 2017; 8:15461. [PMID: 28580940 PMCID: PMC5465316 DOI: 10.1038/ncomms15461] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2016] [Accepted: 03/30/2017] [Indexed: 11/09/2022] Open
Abstract
Free-electron lasers providing ultra-short high-brightness pulses of X-ray radiation have great potential for a wide impact on science, and are a critical element for unravelling the structural dynamics of matter. To fully harness this potential, we must accurately know the X-ray properties: intensity, spectrum and temporal profile. Owing to the inherent fluctuations in free-electron lasers, this mandates a full characterization of the properties for each and every pulse. While diagnostics of these properties exist, they are often invasive and many cannot operate at a high-repetition rate. Here, we present a technique for circumventing this limitation. Employing a machine learning strategy, we can accurately predict X-ray properties for every shot using only parameters that are easily recorded at high-repetition rate, by training a model on a small set of fully diagnosed pulses. This opens the door to fully realizing the promise of next-generation high-repetition rate X-ray lasers.
Collapse
Affiliation(s)
| | - P Micaelli
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - C Olivier
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - T R Barillot
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - M Ilchen
- Stanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,European XFEL GmbH, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A A Lutman
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Marinelli
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - T Maxwell
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Achner
- European XFEL GmbH, Holzkoppel 4, 22869 Schenefeld, Germany
| | - M Agåker
- Department of Physics and Astronomy, Uppsala University, Uppsala 75120, Sweden
| | - N Berrah
- Department of Physics, University of Connecticut, 2152 Hillside Road, U-3046, Storrs, Connecticut 06269, USA
| | - C Bostedt
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - J D Bozek
- Synchrotron SOLEIL, L'Orme des Merisiers, Saint Aubin, 91192 Gif-sur-Yvette, France
| | - J Buck
- Deutsches Elektronen-Synchrotron DESY, Notkestrasse 85, 22607 Hamburg, Germany
| | - P H Bucksbaum
- Stanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,Department of Physics, Stanford University, 382 Via Pueblo Mall, Stanford, California 94305, USA
| | - S Carron Montero
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,Department of Physics, California Lutheran University, 60 West Olsen Road, Thousand Oaks, California 91360, USA
| | - B Cooper
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - J P Cryan
- Stanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Dong
- Department of Physics and Astronomy, Uppsala University, Uppsala 75120, Sweden
| | - R Feifel
- Department of Physics, University of Gothenburg, Origovägen 6B, 41296 Gothenburg, Sweden
| | - L J Frasinski
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - H Fukuzawa
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - A Galler
- European XFEL GmbH, Holzkoppel 4, 22869 Schenefeld, Germany
| | - G Hartmann
- Deutsches Elektronen-Synchrotron DESY, Notkestrasse 85, 22607 Hamburg, Germany.,Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Str 40, 34132 Kassel, Germany
| | - N Hartmann
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - W Helml
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,Physics Department E11, TU Munich, James-Franck-Str 1, 85748 Garching, Germany
| | - A S Johnson
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - A Knie
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Str 40, 34132 Kassel, Germany
| | - A O Lindahl
- Stanford PULSE Institute, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.,Department of Physics, University of Gothenburg, Origovägen 6B, 41296 Gothenburg, Sweden
| | - J Liu
- European XFEL GmbH, Holzkoppel 4, 22869 Schenefeld, Germany
| | - K Motomura
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - M Mucke
- Department of Physics and Astronomy, Uppsala University, Uppsala 75120, Sweden
| | - C O'Grady
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J-E Rubensson
- Department of Physics and Astronomy, Uppsala University, Uppsala 75120, Sweden
| | - E R Simpson
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - R J Squibb
- Department of Physics, University of Gothenburg, Origovägen 6B, 41296 Gothenburg, Sweden
| | - C Såthe
- MAX IV Laboratory, Lund University, Box 118, SE-221 00 Lund, Sweden
| | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan
| | - M Vacher
- Department of Chemistry, Imperial College, London SW7 2AZ, UK.,Department of Chemistry-Ångtröm, Uppsala University, Uppsala 75120, Sweden
| | - D J Walke
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| | - V Zhaunerchyk
- Department of Physics, University of Gothenburg, Origovägen 6B, 41296 Gothenburg, Sweden
| | - R N Coffee
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J P Marangos
- Department of Physics, Imperial College London, London, SW7 2AZ, UK
| |
Collapse
|
96
|
Inoue N, Nishimura N, Takahashi A, Kusano Y, Yamauchi H, Ueda K, Mishima Y, Yokoyama M, Terui Y, Tsuyama N, Takeuchi K, Hatake K. Negative impact of zoledronic acid in R-CHOP treated DLBCL with bone metastasis. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_87] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- N. Inoue
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - N. Nishimura
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - A. Takahashi
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - Y. Kusano
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - H. Yamauchi
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - K. Ueda
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - Y. Mishima
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - M. Yokoyama
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - Y. Terui
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| | - N. Tsuyama
- Pathology; The cancer institute of JFCR; Tokyo Japan
| | - K. Takeuchi
- Pathology Project for Molecular Targets; The cancer institute of JFCR; Tokyo Japan
| | - K. Hatake
- Hematology Oncology; The cancer institute hospital of JFCR; Tokyo Japan
| |
Collapse
|
97
|
Nishimura N, Asaka R, Takeuchi K, Tsuyama N, Inoue N, Takahashi A, Yamauchi H, Kusano Y, Ueda K, Mishima Y, Yokoyama M, Terui Y, Hatake K. Quantitative analysis of MYD88 L265P mutations by digital PCR is an independent prognostic factor for CNS relapse as well as systemic relapse and poor outcome. Hematol Oncol 2017. [DOI: 10.1002/hon.2439] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- N. Nishimura
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - R. Asaka
- Pathology Project for Molecular Targets; The Cancer Institute of JFCR; Tokyo Japan
| | - K. Takeuchi
- Pathology Project for Molecular Targets; The Cancer Institute of JFCR; Tokyo Japan
| | - N. Tsuyama
- Pathology; The Cancer Institute of JFCR; Tokyo Japan
| | - N. Inoue
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - A. Takahashi
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - H. Yamauchi
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - Y. Kusano
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - K. Ueda
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - Y. Mishima
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - M. Yokoyama
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - Y. Terui
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| | - K. Hatake
- Hematology/Oncology; The Cancer Institute Hospital of JFCR; Tokyo Japan
| |
Collapse
|
98
|
Goto H, Kariya R, Kudo E, Okuno Y, Ueda K, Katano H, Okada S. Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma. Oncogene 2017; 36:5252-5262. [PMID: 28481873 DOI: 10.1038/onc.2017.138] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Revised: 03/22/2017] [Accepted: 03/24/2017] [Indexed: 12/20/2022]
Abstract
Primary effusion lymphoma (PEL), which is an aggressive subgroup of B-cell lymphoma associated with Kaposi sarcoma-associated herpes virus/human herpes virus-8, is refractory to the standard treatment, and exhibits a poor survival. Although PU.1 is downregulated in PEL, the potential role of its reduction remains to be elucidated. In this investigation, we analyzed the DNA methylation of PU.1 cis-regulatory elements in PEL and the effect of restoring PU.1 on PEL cells. The mRNA level of PU.1 was downregulated in PEL cells. The methylated promoter and enhancer regions of the PU.1 gene were detected in PEL cells. Suppression of cell growth and apoptosis were caused by the restoration of PU.1 in PEL cells. A microarray analysis revealed that interferon-stimulated genes (ISGs) including pro-apoptotic ISGs were strongly increased in BCBL-1 cells after the induction of PU.1. Reporter assays showed that PU.1 transactivated pro-apoptotic ISG promoters, such as the XAF1, OAS1 and TRAIL promoters. Mutations at the PU.1 binding sequences suppressed its transactivation. We confirmed the binding of PU.1 to the XAF1, OAS1 and TRAIL promoters in a chromatin immunoprecipitation assay. PU.1 suppressed ORF57 activation by inducing IRF7. The reinduction of PU.1 reduced formation of ascites and lymphoma cell infiltration of distant organs in PEL xenograft model mice. Collectively, PU.1 has a role in tumor suppression in PEL and its down-regulation is associated with PEL development. Restoring PU.1 with demethylation agents may be a novel therapeutic approach for PEL.
Collapse
Affiliation(s)
- H Goto
- Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo, Kumamoto, Japan
| | - R Kariya
- Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo, Kumamoto, Japan
| | - E Kudo
- Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo, Kumamoto, Japan
| | - Y Okuno
- Departments of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Graduate School of Medicine, Honjo, Kumamoto, Japan
| | - K Ueda
- Division of Virology, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
| | - H Katano
- Department of Pathology, National Institute of Infectious Diseases, Toyama, Shinjuku, Tokyo, Japan
| | - S Okada
- Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo, Kumamoto, Japan
| |
Collapse
|
99
|
Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Hirofumi Y, Takahashi A, Inoue N, Takeuchi K, Hatake K. Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer J 2017; 7:e558. [PMID: 28430176 PMCID: PMC5436080 DOI: 10.1038/bcj.2017.37] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Revised: 02/25/2017] [Accepted: 03/29/2017] [Indexed: 12/20/2022] Open
Abstract
The absolute peripheral blood lymphocyte count at diagnosis is known to be a strong prognostic factor in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), but it remains unclear as to which peripheral blood lymphocyte population is reflective of DLBCL prognosis. In this cohort, 355 patients with DLBCL treated with R-CHOP from 2006 to 2013 were analyzed. The low absolute CD4+ T-cell count (ACD4C) at diagnosis negatively correlated with the overall response rate and the complete response rate significantly (P<0.00001). An ACD4C<343 × 106/l had a significant negative impact on the 5-year progression-free survival and the overall survival as compared with an ACD4C⩾343 × 106/l (73.7% (95% confidence interval (CI)=66.7-79.5) versus 50.3% (95% CI=39.0-60.6), P<0.00001 and 83.3% (95% CI=77.1-88.0) versus 59.0% (95% CI=47.9-68.5), P<0.00000001, respectively). Multivariate analysis revealed that the ACD4C was an independent prognostic marker (hazard ratio=2.2 (95% CI=1.3-3.7), P<0.01). In conclusion, a low ACD4C at diagnosis served as an independent poor prognostic marker in patients with DLBCL.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived/administration & dosage
- Antibodies, Monoclonal, Murine-Derived/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes/drug effects
- CD4-Positive T-Lymphocytes/pathology
- Cyclophosphamide/administration & dosage
- Cyclophosphamide/adverse effects
- Disease-Free Survival
- Doxorubicin/administration & dosage
- Doxorubicin/adverse effects
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse/blood
- Lymphoma, Large B-Cell, Diffuse/drug therapy
- Lymphoma, Large B-Cell, Diffuse/pathology
- Male
- Middle Aged
- Prednisone/administration & dosage
- Prednisone/adverse effects
- Prognosis
- Rituximab
- Treatment Outcome
- Vincristine/administration & dosage
- Vincristine/adverse effects
Collapse
Affiliation(s)
- Y Kusano
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - M Yokoyama
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Y Terui
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - N Nishimura
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Y Mishima
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - K Ueda
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - N Tsuyama
- Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Y Hirofumi
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - A Takahashi
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - N Inoue
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - K Takeuchi
- Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
- Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - K Hatake
- Department of Hematology Oncology, Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| |
Collapse
|
100
|
You D, Fukuzawa H, Sakakibara Y, Takanashi T, Ito Y, Maliyar GG, Motomura K, Nagaya K, Nishiyama T, Asa K, Sato Y, Saito N, Oura M, Schöffler M, Kastirke G, Hergenhahn U, Stumpf V, Gokhberg K, Kuleff AI, Cederbaum LS, Ueda K. Charge transfer to ground-state ions produces free electrons. Nat Commun 2017; 8:14277. [PMID: 28134238 PMCID: PMC5290264 DOI: 10.1038/ncomms14277] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2016] [Accepted: 12/09/2016] [Indexed: 11/09/2022] Open
Abstract
Inner-shell ionization of an isolated atom typically leads to Auger decay. In an environment, for example, a liquid or a van der Waals bonded system, this process will be modified, and becomes part of a complex cascade of relaxation steps. Understanding these steps is important, as they determine the production of slow electrons and singly charged radicals, the most abundant products in radiation chemistry. In this communication, we present experimental evidence for a so-far unobserved, but potentially very important step in such relaxation cascades: Multiply charged ionic states after Auger decay may partially be neutralized by electron transfer, simultaneously evoking the creation of a low-energy free electron (electron transfer-mediated decay). This process is effective even after Auger decay into the dicationic ground state. In our experiment, we observe the decay of Ne2+ produced after Ne 1s photoionization in Ne-Kr mixed clusters.
Collapse
Affiliation(s)
- D You
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - H Fukuzawa
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - Y Sakakibara
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - T Takanashi
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - Y Ito
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - G G Maliyar
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - K Motomura
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - K Nagaya
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | - T Nishiyama
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | - K Asa
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | - Y Sato
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | - N Saito
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,National Metrology Institute of Japan, AIST, Tsukuba 305-8568, Japan
| | - M Oura
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| | - M Schöffler
- RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan.,Institute for Nuclear Physics, Johann Wolfgang Goethe University Frankfurt, Frankfurt 60438, Germany
| | - G Kastirke
- Institute for Nuclear Physics, Johann Wolfgang Goethe University Frankfurt, Frankfurt 60438, Germany
| | - U Hergenhahn
- Leibniz Institute of Surface Modification, Leipzig 04318, Germany.,Max-Planck-Institute for Plasma Physics, Greifswald 17491, Germany
| | - V Stumpf
- Theoretische Chemie, Physikalisch-Chemisches Institut, Universität Heidelberg, Heidelberg 69120, Germany
| | - K Gokhberg
- Theoretische Chemie, Physikalisch-Chemisches Institut, Universität Heidelberg, Heidelberg 69120, Germany
| | - A I Kuleff
- Theoretische Chemie, Physikalisch-Chemisches Institut, Universität Heidelberg, Heidelberg 69120, Germany
| | - L S Cederbaum
- Theoretische Chemie, Physikalisch-Chemisches Institut, Universität Heidelberg, Heidelberg 69120, Germany
| | - K Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan.,RIKEN SPring-8 Center, Kouto 1-1-1, Sayo, Hyogo 679-5148, Japan
| |
Collapse
|